[HTML][HTML] How and when to use temozolomide to treat aggressive pituitary tumours
BC Whitelaw - Endocrine-related cancer, 2019 - erc.bioscientifica.com
Temozolomide is an oral chemotherapy used to treat aggressive pituitary tumours since
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
[PDF][PDF] How and when to use temozolomide to treat aggressive pituitary tumours
BC Whitelaw - Endocrine-Related Cancer, 2019 - researchgate.net
Temozolomide is an oral chemotherapy used to treat aggressive pituitary tumours since
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
How and when to use temozolomide to treat aggressive pituitary tumours.
BC Whitelaw - Endocrine-related Cancer, 2019 - europepmc.org
Temozolomide is an oral chemotherapy used to treat aggressive pituitary tumours since
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
[PDF][PDF] How and when to use temozolomide to treat aggressive pituitary tumours
BC Whitelaw - Endocrine-Related Cancer, 2019 - scholar.archive.org
Temozolomide is an oral chemotherapy used to treat aggressive pituitary tumours since
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
How and when to use temozolomide to treat aggressive pituitary tumours
BC Whitelaw - Endocrine-Related Cancer, 2019 - erc.bioscientifica.com
Temozolomide is an oral chemotherapy used to treat aggressive pituitary tumours since
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
How and when to use temozolomide to treat aggressive pituitary tumours
BC Whitelaw - Endocrine-Related Cancer, 2019 - cir.nii.ac.jp
抄録< jats: p> Temozolomide is an oral chemotherapy used to treat aggressive pituitary
tumours since 2006. It is inexpensive and well tolerated, the main side effects are fatigue …
tumours since 2006. It is inexpensive and well tolerated, the main side effects are fatigue …
How and when to use temozolomide to treat aggressive pituitary tumours
BC Whitelaw - Endocrine-related cancer, 2019 - pubmed.ncbi.nlm.nih.gov
Temozolomide is an oral chemotherapy used to treat aggressive pituitary tumours since
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …
2006. It is inexpensive and well tolerated, the main side effects are fatigue, nausea and …